Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80
Organisation › Details

Sanofi (Group) [since May 2011]

Sanofi-aventis is the world's third largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, Sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). *

 

Period Start 2011-05-06 renamed
  Predecessor Sanofi-Aventis (Group)
Product Industry pharmaceutical
Person Person Contamine, Jérôme (Sanofi 2009–201809 CFO RETIRED 9/18)
     
Region Region Paris
  Country France
  Street 174 avenue de France
  City 75635 Paris
  Tel +33-1-5377-4000
    Address record changed: 2020-12-02
     
Basic data Employees I: 50,001 to 100,0 (2020-12-31)
  Currency EUR
  Annual sales 36,041,000,000 (sales, net, consolidated (2020) 2020-12-31)
  Profit 12,350,000,000 (2020-12-31)
  Cash 13,915,000,000 (2020-12-31)
     
    * Document for �About Section�: 
     
   
Record changed: 2021-12-31

Advertisement

Picture Kentro Design Is Key to Your Success Berlin 650x100px

More documents for Sanofi (Group) [since May 2011]


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] Fighting Customers 650x100px




» top